Guanhao Biotech Co.,Ltd. (SHE:300238)
14.12
-0.41 (-2.82%)
May 12, 2026, 3:04 PM CST
Guanhao Biotech Revenue
Guanhao Biotech had revenue of 93.44M CNY in the quarter ending March 31, 2026, a decrease of -1.43%. This brings the company's revenue in the last twelve months to 386.40M, up 1.46% year-over-year. In the year 2025, Guanhao Biotech had annual revenue of 387.75M with 2.72% growth.
Revenue (ttm)
386.40M
Revenue Growth
+1.46%
P/S Ratio
9.69
Revenue / Employee
722.24K
Employees
535
Market Cap
3.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 387.75M | 10.27M | 2.72% |
| Dec 31, 2024 | 377.48M | -26.70M | -6.60% |
| Dec 31, 2023 | 404.18M | 26.89M | 7.13% |
| Jan 1, 2023 | 377.29M | -111.70M | -22.84% |
| Jan 1, 2022 | 488.98M | 52.02M | 11.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.81B |
| Qingdao Vland Biotech INC. | 1.40B |
| Beijing Kawin Technology Share-Holding | 1.30B |
| Pulike Biological Engineering | 1.06B |
| Boji Medical Technology | 949.94M |
| Guangdong VTR Bio-Tech | 842.50M |
| Zhejiang Shouxiangu Pharmaceutical | 625.30M |
| Shanghai Shen Lian Biomedical | 272.12M |